ClinicalTrials.gov
ClinicalTrials.gov Menu

Short Daily Hemodialysis and Online HDF: Which One is Better? (SHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00939445
Recruitment Status : Completed
First Posted : July 15, 2009
Last Update Posted : December 15, 2015
Sponsor:
Information provided by (Responsible Party):
Thananda Trakarnvanich, Bangkok Metropolitan Administration Medical College and Vajira Hospital

Brief Summary:

1. To compare the efficacy of

  1. Short Daily Hemodialysis
  2. Online HDF in term of adequacy of dialysis.

Condition or disease Intervention/treatment Phase
End Stage Renal Disease Procedure: Online HDF Procedure: Short Daily Hemodialysis Phase 3

Detailed Description:
The investigators intend to compare the efficacy between these modalities of treatment in terms of adequacy and also other parameters such as calcium-phosphorus balance and hematocrit

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Short Daily Hemodialysis and Online HDF: Which One is Better?
Study Start Date : June 2009
Actual Primary Completion Date : September 2011
Actual Study Completion Date : September 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dialysis
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Online HDF
Online HDF
Procedure: Online HDF
Online HDF
Active Comparator: Short Daily Hemodialysis
Short Daily Hemodialysis
Procedure: Short Daily Hemodialysis
Short Daily Hemodialysis



Primary Outcome Measures :
  1. Adequacy [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. Hematocrit, calcium, phosphorus [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • stable ESRD
  • KT/V > 1.2 for thrice weekly or > 1.8 for twice weekly

Exclusion Criteria:

  • Inadequate vascular access flow rate
  • Concurrent medical illnesses
  • History of non-compliance

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00939445


Locations
Thailand
Renal Unit, BMA Medical College and Vajira Hospital
Bangkok, Thailand, 10300
Sponsors and Collaborators
Bangkok Metropolitan Administration Medical College and Vajira Hospital

Responsible Party: Thananda Trakarnvanich, Associate Professor, Bangkok Metropolitan Administration Medical College and Vajira Hospital
ClinicalTrials.gov Identifier: NCT00939445     History of Changes
Other Study ID Numbers: VJR-NEPHRO001
First Posted: July 15, 2009    Key Record Dates
Last Update Posted: December 15, 2015
Last Verified: December 2015

Additional relevant MeSH terms:
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases